BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 34991834)

  • 1. Quantitative parameters of MRI and
    Gelezhe PB; Blokhin IA; Marapov DI; Morozov SP
    Am J Nucl Med Mol Imaging; 2020; 10(6):279-292. PubMed ID: 33329930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untypical bilateral breast cancer with peritoneal fibrosis on
    Song L; Qiu Y; Huang W; Sun X; Yang Q; Peng Y; Kang L
    Front Med (Lausanne); 2024; 11():1353822. PubMed ID: 38741768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between PET Parameters and Expression of Ki-67 in Breast Cancer.
    Surov A; Meyer HJ; Wienke A
    Transl Oncol; 2019 Feb; 12(2):375-380. PubMed ID: 30522044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between blood lipids and clinicopathological features of breast cancer in young females.
    Jin W; Shan B; Liu H; Li W; Zhang Q; Zhou S; Hu D; Pan Y
    Gland Surg; 2020 Oct; 9(5):1443-1449. PubMed ID: 33224819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis.
    de Mooij CM; Ploumen RAW; Nelemans PJ; Mottaghy FM; Smidt ML; van Nijnatten TJA
    EJNMMI Res; 2023 Jan; 13(1):5. PubMed ID: 36689007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Immune-Based Molecular Subtypes and Prognostic Model in Prostate Adenocarcinoma.
    Guo L; Kang Y; Xia D; Ren Y; Yang X; Xiang Y; Tang L; Ren D; Yu J; Wang J; Liang T
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of SUV
    Diao W; Tian F; Jia Z
    Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of
    Sengoz T; Karakaya YA; Gültekin A; Yaylali O; Senol H; Yuksel D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Jun; ():. PubMed ID: 34090841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of
    Önner H; Coskun N; Erol M; Eren Karanis Mİ
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):11-16. PubMed ID: 34991831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer.
    Arslan E; Çermik TF; Trabulus FDC; Talu ECK; Başaran Ş
    Nucl Med Commun; 2018 Jul; 39(7):680-690. PubMed ID: 29893750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
    Kitajima K; Yamano T; Fukushima K; Miyoshi Y; Hirota S; Kawanaka Y; Miya M; Doi H; Yamakado K; Hirota S
    Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of
    Sengoz T; Karakaya YA; Gultekin A; Yaylali O; Senol H; Yuksel D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):32-38. PubMed ID: 34991834
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.